13Jun/13

NeuroTronik, developing medical device for heart failure, closes $13.1M series A – WRAL Tech Wire

NeuroTronik, developing medical device for heart failure, closes $13.1M series A
WRAL Tech Wire
Chapel Hill, N.C. — NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company’s technology, strategy and financing

and more »

13Jun/13

XOMA Initiates Pilot Trial Studying Gevokizumab in Patients With Pyoderma … – PipelineReview.com (press release)

XOMA Initiates Pilot Trial Studying Gevokizumab in Patients With Pyoderma
PipelineReview.com (press release)
BERKELEY, CA, USA I June 13, 2013 I XOMA Corporation (XOMA), a leader in the discovery and development of therapeutic antibodies, today announced it has opened enrollment in a pilot study to determine gevokizumab’s potential to treat acute 

and more »